Connor, Clark & Lunn Investment Management (CC&L)
MLAB icon

Connor, Clark & Lunn Investment Management (CC&L)’s Mesa Laboratories MLAB Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$841K Sell
9,517
-4,852
-34% -$418K ﹤0.01% 1192
2025
Q4 		$1.13M Buy
+14,369
New +$1.09M ﹤0.01% 1097
2024
Q4 		– Sell
-3,460
Closed -$449K – 1542
2024
Q3 		$449K Buy
+3,460
New +$407K ﹤0.01% 1121

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MLAB Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Mesa Laboratories (MLAB) stake by 34% in Q1 2026, selling an estimated $418K and leaving 9,517 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MLAB in Q3 2024 and has held it in 3 quarters since. The position peaked at $1.13M in Q4 2025. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 9,517 shares of Mesa Laboratories worth $841K as of Q1 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 4,852 Mesa Laboratories shares in Q1 2026, an estimated $418K.
  • Mesa Laboratories made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1192 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Mesa Laboratories in Q3 2024 and has held it in 3 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Mesa Laboratories position peaked at $1.13M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.